Risk factors and temporal patterns of recurrences in patients with vulvar cancer: implications for follow-up intervals and duration

Elit L, Reade CJ (2015) Recommendations for follow-up care for gynecologic cancer survivors. Obstet Gynecol 126:1207–1214. https://doi.org/10.1097/AOG.0000000000001129

Fonseca-Moutinho JA, Coelho MC, Silva DP (2000) Vulvar squamous cell carcinoma. Prognostic factors for local recurrence after primary en bloc radical vulvectomy and bilateral groin dissection. J Reprod Med 45:672–678 (PMID: 10986688)

Gillison ML, Chaturvedi AK, Lowy DR (2008) HPV prophylactic vaccines and the potential prevention of noncervical cancers in both men and women. Cancer 113:3036–3046. https://doi.org/10.1002/cncr.23764

Gonzalez Bosquet J, Magrina JF, Gaffey TA, Hernandez JL, Webb MJ, Cliby WA, Podratz KC (2005) Long-term survival and disease recurrence in patients with primary squamous cell carcinoma of the vulva. Gynecol Oncol 97:828–833. https://doi.org/10.1016/j.ygyno.2005.03.006

Koh W, Greer BE, Abu-Rustum NR, Campos SM, Cho KR, Chon HS, Chu C, Cohn D, Crispens MA, Dizon DS, Dorigo O, Eifel PJ, Fisher CM, Frederick P, Gaffney DK, Han E, Higgins S, Huh WK, Lurain JR III, Mariani A, Mutch D, Nagel C, Nekhlyudov L, Fader AN, Remmenga SW, Reynolds RK, Tillmanns T, Ueda S, Valea FA, Wyse E, Yashar CM, McMillian N, Scavone J (2017) Vulvar cancer, Version 1.2017, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw 15(1):92–120. https://doi.org/10.6004/jnccn.2017.0008

Raspagliesi F, Hanozet F, Ditto A, Solima E, Zanaboni F, Vecchione F, Kusamura S (2006) Clinical and pathological prognostic factors in squamous cell carcinoma of the vulva. Gynecol Oncol 102:333–337. https://doi.org/10.1016/j.ygyno.2005.12.027

Robert Koch Institut (2017) Krebs in Deutschland. https://www.krebsdaten.de/Krebs/DE/Content/Publikationen/Krebs_in_Deutschland. Accessed 5 Dec 2021

Salom EM, Penalver M (2002) Recurrent vulvar cancer. Curr Treat Options Oncol 3:143–153. https://doi.org/10.1007/s11864-002-0060-x

Schnürch HG, Ackermann S, Alt CD, Barinoff J, Böing C, Dannecker C, Gieseking F, Günthert A, Hantschmann P, Horn LC, Kürzl R, Mallmann P, Marnitz S, Mehlhorn G, Hack CC, Koch MC, Torsten U, Weikel W, Wölber L, Hampl M (2016) Diagnosis, therapy and follow-up care of vulvar cancer and its precursors. Guideline of the DGGG and DKG (S2k-Level, AWMF Registry Number 015/059, November 2015. Geburtshilfe Frauenheilkd 76(10):1035–1049. https://doi.org/10.1055/s-0042-103728 (PMID: 27765958; PMCID: PMC5066425)

Zapardiel I, Iacoponi S, Coronado PJ, Zalewski K, Chen F, Fotopoulou C, Dursun P, Kotsopoulos IC, Jach R, Buda A, Martinez-Serrano MJ, Grimm C, Fruscio R, Garcia E, Sznurkowski JJ, Ruiz C, Noya MC, Barazi D, Diez J, Diaz De la Noval B, Bartusevicius A, De Iaco P, Otero M, Diaz M, Haidopoulos D, Franco S, Blecharz P, Zuñiga MA, Rubio P, Gardella B, Papatheodorou DC, Yildirim Y, Fargas F, Macuks R, VULCAN Study coinvestigators (2020) Prognostic factors in patients with vulvar cancer: the VULCAN study. Int J Gynecol Cancer 30:1285–1291. https://doi.org/10.1136/ijgc-2019-000526